NIH-funded research R01 grant

Cx26 Gap Junctions and Early Deafness: How Connexin 26 Deficiency Shapes Cochlear Development

Official title: Connexin Function and Mechanisms of Cx26 Deficiency Induced Hearing Loss

Funded at Yale University · NIH-11337479 · Data updated 2026-11-12

Researchers are studying how lack of Connexin 26 affects the developing ear and leads to congenital or early hearing loss in children.

More Hearing Loss research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startJuly 19, 2021
Project endMay 31, 2027
Funding year2026
Award (this year)$528,660
NIH project number5R01DC019687-06
Project IDNIH-11337479 on NIH RePORTER

Who could benefit from this research

Could help

Children with congenital or early-onset hearing loss linked to GJB2/Connexin 26 mutations or similar cochlear developmental disorders.

Less likely to help

If a patient's hearing loss is caused by factors other than Connexin 26 deficiency, the direct benefit may be limited.

What this research studies

This project investigates how mutations in the GJB2 gene, which encodes Connexin 26, disrupt cochlear development and contribute to hearing loss. Using mouse models, the team will examine why developmental disorders in the cochlea, rather than hair cell loss alone, drive congenital deafness and how later hearing impairment relates to outer hair cell function. The work aims to uncover the cellular and molecular mechanisms of Connexin 26 deficiency so that future therapies can target the root causes. Although previous gene therapy attempts have fallen short, the researchers will build a deeper understanding of Connexin 26 roles in the cochlea to inform new treatment approaches for human patients.

Why it matters

Potential benefit: A better understanding of Connexin 26 function could lead to targeted strategies to prevent or mitigate congenital and early-onset deafness in children.

How similar studies have gone: Previous work shows Connexin 26 is crucial for cochlear development, but exact mechanisms are still being clarified, making this a promising but not yet proven path.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Zhao, Hong-Bo — Yale University
  • Study coordinator: Zhao, Hong-Bo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.